Work

Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

Year: 2008

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e31817c6b68

Authors: Mary E.R. O'Brien, Mark A. Socinski, Alexander Y. Popovich, Igor N. Bondarenko, Antoaneta Tomova, Borys T. Bilynsky˘ı, Yevhen S. Hotko, Valentin L. Ganul, Ippolit Y. Kostinsky, Amy J. Eisenfeld, Larissa Sandalic, Fred B. Oldham, Bruce Bandstra, Alan B. Sandler, Jack W. Singer

Institutions: Royal Marsden Hospital, University of North Carolina at Chapel Hill, Donetsk National Medical University, Dnipro State Medical University, Danylo Halytsky Lviv National Medical University, Uzhhorod National University, Ivano-Frankivsk National Medical University, Vanderbilt University, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2077118523

FWCI: 10.42

Cites: 19

Cited by: 125

Related to: 10